AIC
EBS icon

Ameritas Investment Company’s Emergent Biosolutions EBS Stock Holding History

Ameritas Investment Company’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-106
Closed -$9.85K – 1079
2021
Q1 		$9.85K Buy
+106
New +$10.9K ﹤0.01% 1532
2020
Q2 		– Sell
-100
Closed -$6K – 626
2020
Q1 		$6K Buy
+100
New +$5.76K ﹤0.01% 1317
2019
Q1 		– Sell
-154
Closed -$9K – 1191
2018
Q4 		$9K Buy
+154
New +$9.93K ﹤0.01% 1071

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameritas Investment Company's EBS Position: Q2 2021 in Review

Ameritas Investment Company sold out of Emergent Biosolutions (EBS) in Q2 2021, closing a stake of 106 shares — an estimated $9.85K sold.

Ameritas Investment Company first reported a position in EBS in Q4 2018 and held it in 3 quarters. The position peaked at $9.85K in Q1 2021. 290 funds tracked by Wall St. Rank hold EBS as of Q2 2021.

  • Ameritas Investment Company reported no remaining Emergent Biosolutions position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Company sold 106 Emergent Biosolutions shares in Q2 2021, an estimated $9.85K.
  • Ameritas Investment Company first reported a position in Emergent Biosolutions in Q4 2018 and held it in 3 quarters.
  • Ameritas Investment Company's Emergent Biosolutions position peaked at $9.85K in Q1 2021.
  • 290 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.